IPG Photonics Corp (IPGP) company profile

IPG Photonics Corporation designs, manufactures, and sells high-performance fiber lasers, diode lasers, fiber amplifiers, and laser-based systems. It also provides complementary accessories, including optical delivery cables, processing heads, chillers, and inline monitoring sensors, alongside surface cleaning systems. The company categorizes its primary offerings across materials processing, medical procedures, and advanced applications. Its laser solutions serve diverse manufacturing end markets such as general industrial, automotive, consumer electronics, and medical device fabrication. IPG distributes products globally to original equipment manufacturers, system integrators, and direct end users through a dedicated direct sales team.

The company operates major manufacturing facilities in the United States and Germany, complemented by global sales and service offices and application laboratories. IPG employs approximately 4,840 full-time staff across more than thirty locations in twenty-four countries, with the majority located in the US and Germany. IPG Photonics maintains its principal executive headquarters in Marlborough, Massachusetts.

Summary of the business section of IPG Photonics's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“Per Share Total Public offering price $ 16.500 $ 148,500,000 Underwriting discount $ 1.155 $ 10,395,000 Proceeds, before expenses, to IPG Photonics $ 15.345 $ 95,773,961 Proceeds, before expenses, to selling stockholders $ 15.345 $ 42,331,039 The underwriters may also purchase up to an additional 1,350,000 shares o”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

“As of December 31, 2025, we had approximately 4,840 full-time employees, including 440 in research and development, 3,590 in manufacturing and service operations, 390 in sales and marketing, and 420 in general and administrative functions.”